Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
4.850
-0.050 (-1.02%)
Nov 20, 2025, 4:00 PM EST - Market closed
Compass Therapeutics Revenue
In the year 2024, Compass Therapeutics had annual revenue of $850.00K.
Revenue (ttm)
$850.00K
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
35
Market Cap
862.63M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 850.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
CMPX News
- 15 days ago - Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewsWire
- 16 days ago - Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting - GlobeNewsWire
- 17 days ago - Compass Therapeutics to Participate in Upcoming November Investor Events - GlobeNewsWire
- 2 months ago - Compass Therapeutics, Inc. (CMPX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 3 months ago - Compass Therapeutics to Participate in Upcoming September Investor Events - GlobeNewsWire
- 3 months ago - Compass Therapeutics: Finding Their Way With More Positive Updates In BTC - Seeking Alpha
- 3 months ago - Compass Therapeutics Announces Pricing of Upsized $120 Million Public Offering - GlobeNewsWire
- 3 months ago - Compass Therapeutics Announces Proposed Public Offering - GlobeNewsWire